Sun Pharma USFDA nod for anti hypertensive drug
Sun Pharmaceutical Industries said it has got approval for its Abbreviated New Drug Application for generic version of Quinapril Hydrochloride tablets used in treatment of hypertension and congested heart failure.
By PTI |
MUMBAI: Sun Pharmaceutical Industries on Friday said it has got the approval for its Abbreviated New Drug Application (ANDA) for the generic version of Quinapril Hydrochloride tablets used in the treatment of hypertension and congested heart failure.
The Quinapril Hydrochloride Tablets are generic version of 'Accupril' tablets from Pfizer's portfolio and are available in four strengths, the company said in a filing to Bombay Stock Exchange.
The drug have annual sales of approximately $ 45 million in US, it added.
The Quinapril Hydrochloride Tablets are generic version of 'Accupril' tablets from Pfizer's portfolio and are available in four strengths, the company said in a filing to Bombay Stock Exchange.
The drug have annual sales of approximately $ 45 million in US, it added.
Start a SIP with as low as ₹500 with ET Money App!
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
